Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Blood|September 29, 2005
Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in miceAjay K Malik, Megan E Baldwin, Franklin Peale, et al.
Molecular and Cellular Biology|June 4, 2008
Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryosPaula Haiko, Taija Makinen, Salla Keskitalo, et al.
The Journal of Experimental Medicine|September 10, 2003
Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-DBradley K McColl, Megan E Baldwin, Sally Roufail, et al.
Molecular and Cellular Biology|March 4, 2005
Vascular endothelial growth factor D is dispensable for development of the lymphatic systemMegan E Baldwin, Michael M Halford, Sally Roufail, et al.
Translational Vision Science & Technology|December 19, 2024
Phase 1b Dose Escalation Study of Sozinibercept Inhibition of Vascular Endothelial Growth Factors C and D With Aflibercept for Diabetic Macular EdemaDavid S Boyer, Nathan C Steinle, Joel A Pearlman, et al.
Ophthalmology|February 8, 2023
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular DegenerationTimothy L Jackson, Jason Slakter, Marc Buyse, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 7, 2003
Regenerating lizard tails: a new model for investigating lymphangiogenesisChristopher B Daniels, Benjamin C Lewis, Chris Tsopelas, et al.
Ophthalmology. Retina|January 12, 2020
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular DegenerationPravin U Dugel, David S Boyer, Andrew N Antoszyk, et al.
Novartis Foundation Symposium|May 31, 2007
Molecular pathways for lymphangiogenesis and their role in human diseaseSteven A Stacker, Rae H Farnsworth, Tara Karnezis, et al.
Pageof 3